Plasma catecholamine concentrations during a 72-hour aminophylline infusion in children with acute asthma

T Ishizaki1, A Minegishi, M Morishita

  • 1Division of Clinical Pharmacology, National Medical Center, Tokyo, Japan.

Insights

Theophylline treatment for asthma exacerbations increases catecholamines like norepinephrine and epinephrine. This study found theophylline improved lung function (PEF) but didn't directly correlate with catecholamine levels.

Area of Science:

  • Pharmacology
  • Pediatric Asthma
  • Respiratory Medicine

Background:

  • Theophylline is a bronchodilator used for asthma.
  • Its mechanism may involve adrenomedullary catecholamine secretion.

Purpose of the Study:

  • To investigate if theophylline stimulates catecholamine release from the adrenal medulla.
  • To examine the relationship between theophylline, catecholamines, and lung function in children with asthma.

Main Methods:

  • Nine children with acute asthma exacerbations received a 72-hour aminophylline infusion.
  • Plasma levels of theophylline, norepinephrine (NE), and epinephrine (E) were measured.
  • Peak expiratory flow (PEF) was also monitored at various time points.

Main Results:

  • Theophylline infusion significantly increased plasma NE and E levels compared to baseline.
  • Plasma epinephrine returned towards baseline by 72 hours, while norepinephrine remained elevated.
  • Peak expiratory flow (PEF) increased significantly throughout the infusion.

Conclusions:

  • Theophylline administration leads to increased plasma catecholamines in children with asthma.
  • While theophylline improved lung function, the improvement did not directly correlate with increased epinephrine levels.
  • The study suggests a complex interaction between theophylline, catecholamines, and bronchodilation in asthma management.

Related Concept Videos

Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...